Hologic Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Good afternoon, and welcome to the Bank of America 2020 Healthcare Conference. This is Ivy Ma, Diagnostic Analyst here at BofA. I'm pleased to be joined by Hologic's CFO, Karleen Oberton; as well as Head of Investor Relations, Mike Watts. Thank you so much for joining us today.
We have a pretty ambitious agenda today, and we'll try to take some investor questions from the webcast. So I'll turn it over to Karleen. I think you have some quick intro remarks to kick it off. Thanks.
Thanks, Ivy. And thanks for hosting us on the call today. So let me just start about Hologic a little bit, it is a global medical device company; and one of our hallmarks is market leading, clinically differentiated products, including our Panther fully automated high-through instrumentation for molecular diagnostics testing. And while there is a lot of uncertainty in the world right now, we know 2 things. First, our business was performing very well pre-COVID with 5.2% growth
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |